Who depends on No Individual
1 listed supplier reports No Individual as a customer worth 10% or more of their revenue, led by Sarepta Therapeutics at 10%.
Get an email when No Individual's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on No Individual
Listed companies whose annual report names No Individual as a customer worth 10% or more of their revenue. If No Individual cuts orders or switches supplier, these are the companies that feel it.
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Sarepta TherapeuticsSRPT | 10% | from 10% | 3 years | FY 2025 · filed 2 Mar 2026 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API